Applied Therapeutics, Inc. — Director's Dealing 2022

Sep 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-09-14

Reporting Person: MARCUS JOEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-14	Common Stock	M	7389	$1.05	Acquired	390184	Direct
2022-09-14	Common Stock	M	10230	$1.05	Acquired	400414	Direct
2022-09-14	Common Stock	M	16500	$1.05	Acquired	416914	Direct
2022-09-14	Common Stock	M	4125	$1.05	Acquired	421039	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-14	Employee Stock Option (Right to Buy)	$1.05	M	7389	Disposed	2029-05-12	Common Stock (7389)	Direct
2022-09-14	Employee Stock Option (Right to Buy)	$1.05	M	10230	Disposed	2030-06-03	Common Stock (10230)	Direct
2022-09-14	Employee Stock Option (Right to Buy)	$1.05	M	16500	Disposed	2031-06-02	Common Stock (16500)	Direct
2022-09-14	Employee Stock Option (Right to Buy)	$1.05	M	4125	Disposed	2032-06-02	Common Stock (4125)	Direct

Footnotes

F1: Includes 67,435 shares previously reported as indirectly held through a family trust of which the reporting person and his spouse are trustees. In accordance with SEC guidance with respect to shares held by living trusts, such shares are now included in the shares directly owned by the reporting person.

F2: These Options are fully vested.

F3: Reflects an initial grant of 16,500 Options granted on June 3, 2022 to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.